SCHEMBL159502

SCHEMBL159502

NC(=O)c1cc(O)[nH]n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL165390 0.81
SCHEMBL27452564 0.77
SCHEMBL4035315 0.77
SCHEMBL159501 0.77
SCHEMBL1827221 0.77 MAPK1 (0.47)
SCHEMBL4708946 0.77
Potassium Ion SCHEMBL29224327 0.76 HCAR2 (0.41)
SCHEMBL20029123 0.76
SCHEMBL15556627 0.76
SCHEMBL30587528 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040019046-A1 Phenylacetamido-pyrazole derivatives and their use as antitumor agents PHARMACIA ITALIA SPA (IT) 2004-01-29 US claimed
US-9856210-B2 Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis KYOTO UNIVERSITY (JP) 2018-01-02 US disclosed
US-20170217901-A1 PROCESS FOR THE PREPARATION OF PYRAZOLE-4-CARBOXAMIDES SOLVAY SA (BE) 2017-08-03 US disclosed
EP-3174857-A1 PROCESS FOR THE PREPARATION OF PYRAZOLE-4-CARBOXAMIDES Solvay SA (BE) 2017-06-07 EP disclosed
EP-2611437-B1 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS UNIV KYOTO (JP) 2017-03-29 EP disclosed
CN-102596913-B Cannabinoid receptor modulators 艾尼纳制药公司 2016-11-09 CN disclosed
WO-2016016298-A1 PROCESS FOR THE PREPARATION OF PYRAZOLE-4-CARBOXAMIDES SOLVAY SA (BE) 2016-02-04 WO disclosed
EP-2980078-A1 Process for the preparation of pyrazole-4-carboxamides Solvay SA (BE) 2016-02-03 EP disclosed
US-20130225642-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS KYOTO UNIVERSITY (JP) 2013-08-29 US disclosed
EP-2611437-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Kyoto University (JP) 2013-07-10 EP disclosed
WO-2012029994-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS KYOTO UNIVERSITY (JP) 2012-03-08 WO disclosed
US-20040019046-A1 Phenylacetamido-pyrazole derivatives and their use as antitumor agents PHARMACIA ITALIA SPA (IT) 2004-01-29 US disclosed
EP-1345909-A1 PHENYLACETAMIDO-PYRAZOLE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS Pharmacia Italia S.p.A. (IT) 2003-09-24 EP disclosed
WO-2002048114-A1 PHENYLACETAMIDO- PYRAZOLE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA S.P.A. (IT) 2002-06-20 WO disclosed
EP-0697623-B1 Silver halide photographic material containing pyrazolone-pentamethine oxonol dye FUJI PHOTO FILM CO LTD (JP) 1998-03-25 EP disclosed
US-5633390-A CONTROLLING LIGHT ABSORBED; CANBE BLEACHED OR DISSOVED IN PROCESSING SOLUTION; STABILITY FUJI PHOTO FILM CO., LTD. (JP) 1997-05-27 US disclosed
US-5563028-A DYES HAVE SPECIFIC SPECTRAL ABSORPTION, CHEMICAL INACTIVITY IN PHOTOGRAPHIC REACTIONS, BLEACHABLE OR DISSOLUTION, PHOTOSTABILITY AND COLORFASTNESS FUJI PHOTO FILM CO., LTD. (JP) 1996-10-08 US disclosed
EP-0697623-A1 Silver halide photographic material containing pyrazolone-pentamethine oxonol dye FUJI PHOTO FILM CO., LTD. (JP) 1996-02-21 EP disclosed